🎉 M&A multiples are live!
Check it out!

Innoscripta Valuation Multiples

Discover revenue and EBITDA valuation multiples for Innoscripta and similar public comparables like Xero, Reckon, and Cape Range.

Innoscripta Overview

About Innoscripta

Innoscripta SE is a software company specializing in cloud-based compliance software for research and development. It provides R&D tax incentives consulting.


Founded

2012

HQ

Germany
Employees

n/a

Website

innoscripta.com

Financials

Last FY Revenue $76.2M

Last FY EBITDA $44.4M

EV

$1.2B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 12K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Innoscripta Financials

In the most recent fiscal year, Innoscripta achieved revenue of $76.2M and an EBITDA of $44.4M.

Innoscripta expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Innoscripta valuation multiples based on analyst estimates

Innoscripta P&L

NTM Last FY FY 2025 FY 2026 FY 2027
Revenue XXX $76.2M XXX XXX XXX
Gross Profit XXX $74.5M XXX XXX XXX
Gross Margin XXX 98% XXX XXX XXX
EBITDA XXX $44.4M XXX XXX XXX
EBITDA Margin XXX 58% XXX XXX XXX
EBIT XXX $44.0M XXX XXX XXX
EBIT Margin XXX 58% XXX XXX XXX
Net Profit XXX $29.6M XXX XXX XXX
Net Margin XXX 39% XXX XXX XXX
Net Debt XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Innoscripta Stock Performance

As of July 14, 2025, Innoscripta's stock price is EUR 104 (or $123).

Innoscripta has current market cap of EUR 1.0B (or $1.2B), and EV of EUR 1.0B (or $1.2B).

See Innoscripta trading valuation data

Innoscripta Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$1.2B $1.2B XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Innoscripta Valuation Multiples

As of July 14, 2025, Innoscripta has market cap of $1.2B and EV of $1.2B.

Innoscripta's trades at 15.6x EV/Revenue multiple, and 26.9x EV/EBITDA.

Equity research analysts estimate Innoscripta's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Innoscripta's P/E ratio is not available.

See valuation multiples for Innoscripta and 12K+ public comps

Innoscripta Financial Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $1.2B XXX $1.2B XXX XXX XXX
EV (current) $1.2B XXX $1.2B XXX XXX XXX
EV/Revenue n/a XXX 15.6x XXX XXX XXX
EV/EBITDA n/a XXX 26.9x XXX XXX XXX
EV/EBIT n/a XXX 27.1x XXX XXX XXX
EV/Gross Profit n/a XXX n/a XXX XXX XXX
P/E n/a XXX 41.6x XXX XXX XXX
EV/FCF n/a XXX 50.6x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Innoscripta Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Innoscripta Margins & Growth Rates

Innoscripta's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

Innoscripta's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Innoscripta's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Innoscripta and other 12K+ public comps

Innoscripta Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth n/a XXX 48% XXX XXX XXX
EBITDA Margin n/a XXX 58% XXX XXX XXX
EBITDA Growth n/a XXX 88% XXX XXX XXX
Rule of 40 n/a XXX n/a XXX XXX XXX
Bessemer Rule of X XXX XXX n/a XXX XXX XXX
Revenue per Employee XXX XXX n/a XXX XXX XXX
Opex per Employee XXX XXX n/a XXX XXX XXX
S&M Expenses to Revenue XXX XXX n/a XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX n/a XXX XXX XXX
Opex to Revenue XXX XXX 40% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Innoscripta Public Comps

See public comps and valuation multiples for Financial Management Software comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Cape Range XXX XXX XXX XXX XXX XXX
Credit Clear XXX XXX XXX XXX XXX XXX
IODM XXX XXX XXX XXX XXX XXX
Reckon XXX XXX XXX XXX XXX XXX
Xero XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Innoscripta M&A and Investment Activity

Innoscripta acquired  XXX companies to date.

Last acquisition by Innoscripta was  XXXXXXXX, XXXXX XXXXX XXXXXX . Innoscripta acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Innoscripta

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Start Free Trial

About Innoscripta

When was Innoscripta founded? Innoscripta was founded in 2012.
Where is Innoscripta headquartered? Innoscripta is headquartered in Germany.
Is Innoscripta publicy listed? Yes, Innoscripta is a public company listed on FRA.
What is the stock symbol of Innoscripta? Innoscripta trades under 1INN ticker.
When did Innoscripta go public? Innoscripta went public in 2025.
Who are competitors of Innoscripta? Similar companies to Innoscripta include e.g. Cape Range, Credit Clear, IODM, Reckon.
What is the current market cap of Innoscripta? Innoscripta's current market cap is $1.2B
Is Innoscripta profitable? Yes, Innoscripta is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.